XML 80 R38.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Summary Of Segment Performance



		For the Three Months Ended June 30,
			CAG		Water			LPD			Other			Unallocated Amounts			Consolidated Total
2015
Revenue		$	351,620		$	25,051		$	32,059		$	4,613		$	-		$	413,343

Income (loss) from operations		$	67,875		$	11,954		$	5,895		$	(237)		$	2,816		$	88,303
Interest expense, net																		(6,700)
Income before provision for income taxes																		81,603
Provision for income taxes																		24,665
Net income																		56,938
Less: Net income attributable to noncontrolling interest																		26
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	56,912

2014
Revenue		$	322,129		$	24,487		$	37,307		$	6,199		$	-		$	390,122

Income (loss) from operations		$	66,924		$	10,064		$	10,747		$	(249)		$	(4,267)		$	83,219
Interest expense, net																		(2,477)
Income before provision for income taxes																		80,742
Provision for income taxes																		23,498
Net income																		57,244
Less: Net income attributable to noncontrolling interest																		26
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	57,218


		For the Six Months Ended June 30,
			CAG		Water			LPD			Other			Unallocated Amounts			Consolidated Total
2015
Revenue		$	676,151		$	46,749		$	63,329		$	9,591		$	-		$	795,820

Income (loss) from operations		$	120,304		$	21,413		$	11,846		$	(431)		$	7,974		$	161,106
Interest expense, net																		(12,579)
Income before provision for income taxes																		148,527
Provision for income taxes																		45,011
Net income																		103,516
Less: Net income attributable to noncontrolling interest																		10
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	103,506

2014
Revenue		$	620,857		$	45,908		$	71,518		$	12,042		$	-		$	750,325

Income (loss) from operations		$	120,928		$	18,180		$	19,067		$	340		$	(5,250)		$	153,265
Interest expense, net																		(4,780)
Income before provision for income taxes																		148,485
Provision for income taxes																		44,648
Net income																		103,837
Less: Net income attributable to noncontrolling interest																		34
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	103,803

Summary Of Revenue By Product And Service Category


		For the Three Months Ended						For the Six Months Ended
		June 30,						June 30,
			2015			2014			2015			2014
CAG segment revenue:
CAG Diagnostics recurring revenue:		$	300,146		$	276,949		$	578,911		$	532,830
IDEXX VetLab® consumables			100,743			89,113			199,135			173,434
VetLab service and accessories			14,018			13,433			27,548			26,504
Rapid assay products			52,182			49,493			95,819			92,552
Reference laboratory diagnostic and consulting services			133,203			124,910			256,409			240,340
CAG Diagnostics capital - instruments			24,064			18,993			44,178			37,580
Customer information management and digital imaging systems			27,410			26,187			53,062			50,447
CAG segment revenue			351,620			322,129			676,151			620,857

Water segment revenue			25,051			24,487			46,749			45,908
LPD segment revenue			32,059			37,307			63,329			71,518
Other segment revenue			4,613			6,199			9,591			12,042
Total revenue		$	413,343		$	390,122		$	795,820		$	750,325